Your fact-checks will appear here
Brussels-based trade association
or failure to share individual participant data (IPD) does materially impede scientific verification, secondary analyses, and cumulative knowledge-building, but it does not exist in a vacuum: legitima...
and international requirements for clinical trial data disclosure are a patchwork of statutes, binding regulator rules, and voluntary industry and journal commitments: regulators and companies routine...
Public commitments to share de‑identified individual participant data (IPD) exist across the industry — notably the PhRMA/EFPIA pledge effective 1 January 2014 — but audits and reviews show that concr...
Vaccine trial sponsors typically release high-level documents — trial registrations, protocols or protocol synopses, journal articles and summary results — while retaining detailed regulatory dossiers...